Skip to Main Content

Author Details

Jonathan R Pollack
Stanford University School of Medicine
1987
115
57
PMIDPaper TitleJournal TitlePublished Year
34854277The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements.Haematologica2022
35801943RE: Lower Exome Sequencing Coverage of Ancestrally African Patients in the Cancer Genome Atlas.J Natl Cancer Inst2022
35689405New Ameloblastoma Cell Lines Enable Preclinical Study of Targeted Therapies.J Dent Res2022
33054061The long non-coding RNA <i>Cancer Susceptibility 15</i> (<i>CASC15</i>) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia.Haematologica2020
31895100Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland Tumors.Am J Surg Pathol2020
30520817The HTN3-MSANTD3 Fusion Gene Defines a Subset of Acinic Cell Carcinoma of the Salivary Gland.Am J Surg Pathol2019
31663018PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer.Sci Adv2019
31406151A common phytoene synthase mutation underlies white petal varieties of the California poppy.Sci Rep2019
30741938Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancer.Oncogenesis2019
31094703Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis.JCI Insight2019
29124284Ca<sup>2+</sup>/nuclear factor of activated T cells signaling is enriched in early-onset rectal tumors devoid of canonical Wnt activation.J Mol Med (Berl)2018
29383790XPNPEP3 is a novel transcriptional target of canonical Wnt/β-catenin signaling.Genes Chromosomes Cancer2018
29190909Genes co-amplified with <i>ERBB2</i> or <i>MET</i> as novel potential cancer-promoting genes in gastric cancer.Oncotarget2017
28212443Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.PLoS One2017
28423633Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.Oncotarget2017
29515757SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents.Oncotarget2017
25926124Ameloblastoma: a clinical review and trends in management.Eur Arch Otorhinolaryngol2016
27651290BRAF inhibitor therapy of primary ameloblastoma.Oral Surg Oral Med Oral Pathol Oral Radiol2016
27325561Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.Prostate2016
27209484BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response.Oral Surg Oral Med Oral Pathol Oral Radiol2016
25923013SIRT7 inactivation reverses metastatic phenotypes in epithelial and mesenchymal tumors.Sci Rep2015
26556242Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer.PLoS One2015
23168910Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India.Mol Carcinog2014
24859340Identification of recurrent SMO and BRAF mutations in ameloblastomas.Nat Genet2014
22797070EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms.Oncogene2013
24041470Integrative genomic and functional profiling of the pancreatic cancer genome.BMC Genomics2013
24040285Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis.PLoS One2013
23637631Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.PLoS Genet2013
23660946ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines.Br J Cancer2013
23355908The spectrum of SWI/SNF mutations, ubiquitous in human cancers.PLoS One2013
22179824Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness.Oncogene2012
23112155CDX2 is an amplified lineage-survival oncogene in colorectal cancer.Proc Natl Acad Sci U S A2012
22929540Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.Genome Biol2012
22233809Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.Proc Natl Acad Sci U S A2012
21383983Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.PLoS One2011
21887346SMURF1 amplification promotes invasiveness in pancreatic cancer.PLoS One2011
21629784A tri-marker proliferation index predicts biochemical recurrence after surgery for prostate cancer.PLoS One2011
21642389A fused lasso latent feature model for analyzing multi-sample aCGH data.Biostatistics2011
20031972DR-Integrator: a new analytic tool for integrating DNA copy number and gene expression data.Bioinformatics2010
24489618Regularized Multivariate Regression for Identifying Master Predictors with Application to Integrative Genomics Study of Breast Cancer.Ann Appl Stat2010
20534740Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.Clin Cancer Res2010
20663904Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferation.Cancer Res2010
20215510LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.Cancer Res2010
20434415Genomic instability in breast cancer: pathogenesis and clinical implications.Mol Oncol2010
19881546Focal amplification and oncogene dependency of GAB2 in breast cancer.Oncogene2010
19966867Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.Oncogene2010
20064158KIT mutations confer a distinct gene expression signature in core binding factor leukaemia.Br J Haematol2010
19488867DNA microarray technology. Introduction.Methods Mol Biol2009
19582160Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.PLoS One2009
19488881Integration of diverse microarray data types.Methods Mol Biol2009
  • 1 - 50 of 115

Recommended Authors

Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 1
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 10
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Raj Chari
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 3
Bin Feng
The First Affiliated Hospital of Jinan University
Career Start Year 2004
Number of shared co-authors 2
Steffen Durinck
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 4
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 8
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 7
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 19
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 3
David S Rickman
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 16
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 5
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 6
Barbara A Weir
Janssen Research and Development LLC
Career Start Year 1997
Number of shared co-authors 18
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 1
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 6
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 13
Bauke Ylstra
Cancer Center Amsterdam, Vrije Universiteit Amsterdam
Career Start Year 1992
Number of shared co-authors 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 18
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 8
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 12
Wan L Lam
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 12
Mark A Watson
Washington University School of Medicine
Career Start Year 1987
Number of shared co-authors 19
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 6
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 30
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 1
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 11

Collaborators

Young H Kim
Stanford University
Co-authored papers 27
Tina Hernandez-Boussard
Stanford University
Co-authored papers 12
Pei Wang
Co-authored papers 11
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 9
David Botstein
Calico Life Sciences LLC
Co-authored papers 8
Anne-Lise B??rresen-Dale
Institute for Cancer Research, Oslo University Hospital
Co-authored papers 6
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Anna Bergamaschi
Bluestar Genomics Inc.
Co-authored papers 5
James M Sikela
University of Colorado
Co-authored papers 4
Charles M Perou
Co-authored papers 4
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 4
David G Huntsman
University of British Columbia
Co-authored papers 4
Anis Karimpour-Fard
University of Colorado
Co-authored papers 4
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Co-authored papers 3
Michael B Eisen
Howard Hughes Medical Institute, University of California Berkeley
Co-authored papers 2
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 2
Hans A Kestler
Co-authored papers 2
Erik J MacLaren
Wellcome Trust Sanger Institute
Co-authored papers 2
Teri A Longacre
Co-authored papers 2
Jean M Davidson
Stanford University School of Medicine
Co-authored papers 2
Cyril B Gilks
University of British Columbia
Co-authored papers 2
Joanne N Engel
University of California san francisco
Co-authored papers 2
Stephanie Bell
Co-authored papers 1
Arian F A Smit
Co-authored papers 1
Rasmus Nielsen
Co-authored papers 1
Kayla E Smith
Co-authored papers 1
Anand Sethuraman
Stanford University School of Medicine
Co-authored papers 1
Geoffrey Okwuonu
Baylor College of Medicine
Co-authored papers 1
San Juana Ruiz
Co-authored papers 1
Robert M Kuhn
Genomics Institute, University of California Santa Cruz
Co-authored papers 1
Release 1.2